MedTrace Logo

The Effect of Yoga Therapy on Post-operative Side-effects Among Women With Breast Cancer

NCT05820373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 444

Last updated 2023-04-19

No results posted yet for this study

Summary

The present study evaluates the effect of yoga therapy on scarring contractures and shoulder joint motion and range in women diagnosed with breast cancer. A single-blinded prospective, randomized controlled trial will be used.

Conditions

  • Breast Cancer
  • Yoga Therapy
  • Shoulder Joint Motion
  • Scar Contracture

Interventions

BEHAVIORAL

Yoga therapy

Women being allocated to the intervention group will attend a 12-week, bi-weekly, specially designed yoga therapy course. In each yoga class, participants will be taught to perform a standardized yoga sequence including postures and breathing exercise. Each class lasts 60 minutes. A DVD demonstrating the yoga sequence will be given to each participant to prompt daily home practice.

BEHAVIORAL

Active control group

Women being allocated to the active control group will attend a 12-week, weekly, relaxation course. In each relaxation class, participants will be taught to learn mediation and guided relaxation, called Shavasana. Participants will be asked to lie on their back, with legs apart and their eyes closed. During the practice, participants learn how to relax the body and breath normally. Each session lasts 60 minutes.

BEHAVIORAL

Passive control group

The passtive control intervention will be the standard post-operative exercises which are currently introduced to women following surgery, for all women allocated to the control group. A DVD demonstrating the post-operative exercise will be given to participants to practice at home daily.

Sponsors & Collaborators

  • hong Kong Cancer Fund

    collaborator UNKNOWN

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Wendy Wing Tak Lam, PhD · School of Public Health, The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-14
Primary Completion
2018-11-29
Completion
2018-11-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820373 on ClinicalTrials.gov